Status:
COMPLETED
Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy
Lead Sponsor:
Diakonhjemmet Hospital
Conditions:
Spondyloarthritis
Ultrasonography
Eligibility:
All Genders
18-85 years
Brief Summary
Patients with spondylarthritis (SpA) (including ankylosing spondylitis, psoriatic arthritis, arthritis as part of inflammatory bowel disease and reactive arthritis) have axial involvement (the spine) ...
Eligibility Criteria
Inclusion
- SpA
- Planning to start anti-TNF alpha treatment
Exclusion
- Patients not being able to communicate in Norwegian or not being able to fill in questionnaires
- Surgery in more than 5 of the joints/entheses to be examined by US
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01219257
Start Date
September 1 2011
End Date
January 1 2016
Last Update
August 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Rheumatology, Diakonhjemmet Hospital
Oslo, Norway, 0319